Inhibitors of IRAK4 activity
US9598440B2 · kind B2 · utility
4Cited by
0References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 3, 2013 |
| Grant date | Mar 21, 2017 |
| Priority date | — |
| Expiry date | Oct 3, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds which modulate interleukin-1 (IL-1) receptor-associated kinase 4 (IRAK4) and are useful in the prevention or treatment of inflammatory, cell proliferative and immune-related conditions and diseases. Specifically, provided herein are inhibitors of IRAK4 of Formula I and pharmaceutical compositions comprising such inhibitors, as well as methods therewith for treating IRAK4-mediated or -associated conditions or diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.